Alkem Laboratories Ltd. Financials: Quarterly Results
Revenue
3289.71
Cr.
PAT
323.01
Cr.
EBITDA
424.76
Cr.
Alkem Laboratories Ltd. Q4FY25 Financial Metrics
| Indicator | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 3143.75 | 3374.28 | 3414.67 | 3031.82 | 2935.82 |
| Total Income From Operations (Cr.) | 3143.75 | 3374.28 | 3414.67 | 3031.82 | 2935.82 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 424.76 | 767.10 | 808.40 | 648.47 | 406.72 |
| P/L Before Exceptional Items & Tax (Cr.) | 396.34 | 731.07 | 780.26 | 619.36 | 379.86 |
| P/L After Tax from Ordinary Activities (Cr.) | 323.01 | 640.79 | 701.96 | 550.24 | 304.48 |
| Net Profit/Loss For the Period (Cr.) | 323.01 | 640.79 | 701.96 | 550.24 | 304.48 |
| Basic EPS | 25.57 | 52.34 | 57.60 | 45.60 | 24.55 |
FAQs
Alkem Laboratories Ltd. announced its quarterly results for Q4 FY2025 on May 29, 2025.
In Q4 FY2025, Alkem Laboratories Ltd. are as follows:
Revenue: ₹3289.71 crore
Net Profit: ₹323.01 crore.
For Q4 FY2025, Alkem Laboratories Ltd. posted ₹3289.71 crore in revenue and ₹323.01 crore in net profit.
Past quarterly results for Alkem Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.